PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO), is undergoing a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology with an investment of $100 million into the construction and enhancement of world-class facilities at its Bedford, NH campus. This important manufacturing process is commonly used with injectable and biologic therapies. Following PCI’s acquisition of Lyophilization Servic...